23 December 2022 – “It would be very surprising if you ever had a mechanism in nature that would be 100%. Biology never seems to be so clear cut.” That was Roger Reddel’s reaction to his then Ph.D. student Tracy Bryan’s discovery that many cancer cell lines do not express the enzyme telomerase, but still maintain long telomeres throughout the immortalization process. Their 1995 paper “Telomere elongation in immortal human cells without detectable telomerase activity” has been cited over seventeen hundred times. It is included in The EMBO Journal’s 40th-anniversary collection of ground-breaking articles, all free to read. On this episode, Reddel and Bryan discuss how the project began, the key experiments, and the consequences of Alternative Lengthening of Telomeres (ALT) for cancer research. Miguel Godinho Ferreira discusses the paper’s impact in the broader setting of genome instability and DNA repair.
EMBOEncounters:
Biannual EMBO magazine
EMBO newsletters
- Contact
Tilmann Kießling
- Head, Communications
- + 49 160 9019 3839
- Podcast
ALTernative immortality
Roger Reddel and Tracy Bryan tell the story behind their paper in The EMBO Journal showing that cancer cells have more than one way to keep their telomeres
- By Thiago Carvalho
Recent episodes and related news
Perspectives from Vesna Boraska Perica
The Croatian researcher and EMBC Delegate talks about the development of scientific careers
It’s viruses all the way down: a conversation with Hsiao-Han Chang, Gytis Dudas, and Hedvig Tamman
As COVID-19 and flu season descends, we talk with three new research group leaders who work on host-virus interactions